aluates Reports

$ 0.0

Automative

Global Oral Cholera Vaccine Market Research Report 2026

Published Date: 2026-04-22

Report Code: QYRE-Auto-34U7264

Global Oral Cholera Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Oral Cholera Vaccine Market Research Report 2026

Code: QYRE-Auto-34U7264

Report

2026-04-22

Pages:116

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

PaxVax

Sanofi

Valneva

EuBiologics

United Biotech

Vabiotech

Oral Cholera Vaccine Market Size

The global Oral Cholera Vaccine market was valued at US$ 108 million in 2025 and is anticipated to reach US$ 178 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

Oral Cholera Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Oral Cholera Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.

South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.

Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.

This report delivers a comprehensive overview of the global Oral Cholera Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oral Cholera Vaccine. The Oral Cholera Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Oral Cholera Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Oral Cholera Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Oral Cholera Vaccine Market Report

Report Metric	Details
Report Name	Oral Cholera Vaccine Market
Accounted market size in 2025	US$ 108 million
Forecasted market size in 2032	US$ 178 million
CAGR	7.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Euvichol-Plus DUKORAL Shanchol Others
by Application	Preventive Campaigns Outbreak Response
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	PaxVax, Sanofi, Valneva, EuBiologics, United Biotech, Vabiotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Oral Cholera Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Oral Cholera Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Oral Cholera Vaccine Market growing?

Ans: The Oral Cholera Vaccine Market witnessing a CAGR of 7.5% during the forecast period 2026-2032.

What is the Oral Cholera Vaccine Market size in 2032?

Ans: The Oral Cholera Vaccine Market size in 2032 will be US$ 178 million.

What is the EuBiologics share in Oral Cholera Vaccine Market?

Ans: The leading player is EuBiologics, who makes up over 40%.

What is the Oral Cholera Vaccine Market share by region?

Ans: South Korea is the largest producer, with a market share more than 80%, followed by India (10%).

What is the Oral Cholera Vaccine Market share by type?

Ans: Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%.

Who are the main players in the Oral Cholera Vaccine Market report?

Ans: The main players in the Oral Cholera Vaccine Market are PaxVax, Sanofi, Valneva, EuBiologics, United Biotech, Vabiotech

What are the Application segmentation covered in the Oral Cholera Vaccine Market report?

Ans: The Applications covered in the Oral Cholera Vaccine Market report are Preventive Campaigns, Outbreak Response

What are the Type segmentation covered in the Oral Cholera Vaccine Market report?

Ans: The Types covered in the Oral Cholera Vaccine Market report are Euvichol-Plus, DUKORAL, Shanchol, Others

1 Oral Cholera Vaccine Market Overview

1.1 Product Definition

1.2 Oral Cholera Vaccine by Type

1.2.1 Global Oral Cholera Vaccine Market Value by Type: 2025 vs 2032

1.2.2 Euvichol-Plus

1.2.3 DUKORAL

1.2.4 Shanchol

1.2.5 Others

1.3 Oral Cholera Vaccine by Application

1.3.1 Global Oral Cholera Vaccine Market Value by Application: 2025 vs 2032

1.3.2 Preventive Campaigns

1.3.3 Outbreak Response

1.4 Global Oral Cholera Vaccine Market Size Estimates and Forecasts

1.4.1 Global Oral Cholera Vaccine Revenue 2021–2032

1.4.2 Global Oral Cholera Vaccine Sales 2021–2032

1.4.3 Global Oral Cholera Vaccine Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Oral Cholera Vaccine Market Competition by Manufacturers

2.1 Global Oral Cholera Vaccine Sales Market Share by Manufacturers (2021–2026)

2.2 Global Oral Cholera Vaccine Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Oral Cholera Vaccine Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Oral Cholera Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Oral Cholera Vaccine, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Oral Cholera Vaccine, Product Types and Applications

2.7 Global Key Manufacturers of Oral Cholera Vaccine, Date of Entry into the Industry

2.8 Global Oral Cholera Vaccine Market Competitive Situation and Trends

2.8.1 Global Oral Cholera Vaccine Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Oral Cholera Vaccine Players Market Share by Revenue

2.8.3 Global Oral Cholera Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Oral Cholera Vaccine Market Scenario by Region

3.1 Global Oral Cholera Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Oral Cholera Vaccine Sales by Region: 2021–2032

3.2.1 Global Oral Cholera Vaccine Sales by Region: 2021–2026

3.2.2 Global Oral Cholera Vaccine Sales by Region: 2027–2032

3.3 Global Oral Cholera Vaccine Revenue by Region: 2021–2032

3.3.1 Global Oral Cholera Vaccine Revenue by Region: 2021–2026

3.3.2 Global Oral Cholera Vaccine Revenue by Region: 2027–2032

3.4 North America Oral Cholera Vaccine Market Facts & Figures by Country

3.4.1 North America Oral Cholera Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Oral Cholera Vaccine Sales by Country (2021–2032)

3.4.3 North America Oral Cholera Vaccine Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Oral Cholera Vaccine Market Facts & Figures by Country

3.5.1 Europe Oral Cholera Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Oral Cholera Vaccine Sales by Country (2021–2032)

3.5.3 Europe Oral Cholera Vaccine Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Cholera Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Oral Cholera Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Oral Cholera Vaccine Sales by Region (2021–2032)

3.6.3 Asia Pacific Oral Cholera Vaccine Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Oral Cholera Vaccine Market Facts & Figures by Country

3.7.1 Latin America Oral Cholera Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Oral Cholera Vaccine Sales by Country (2021–2032)

3.7.3 Latin America Oral Cholera Vaccine Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oral Cholera Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Cholera Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Oral Cholera Vaccine Sales by Country (2021–2032)

3.8.3 Middle East and Africa Oral Cholera Vaccine Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Oral Cholera Vaccine Sales by Type (2021–2032)

4.1.1 Global Oral Cholera Vaccine Sales by Type (2021–2026)

4.1.2 Global Oral Cholera Vaccine Sales by Type (2027–2032)

4.1.3 Global Oral Cholera Vaccine Sales Market Share by Type (2021–2032)

4.2 Global Oral Cholera Vaccine Revenue by Type (2021–2032)

4.2.1 Global Oral Cholera Vaccine Revenue by Type (2021–2026)

4.2.2 Global Oral Cholera Vaccine Revenue by Type (2027–2032)

4.2.3 Global Oral Cholera Vaccine Revenue Market Share by Type (2021–2032)

4.3 Global Oral Cholera Vaccine Price by Type (2021–2032)

5 Segment by Application

5.1 Global Oral Cholera Vaccine Sales by Application (2021–2032)

5.1.1 Global Oral Cholera Vaccine Sales by Application (2021–2026)

5.1.2 Global Oral Cholera Vaccine Sales by Application (2027–2032)

5.1.3 Global Oral Cholera Vaccine Sales Market Share by Application (2021–2032)

5.2 Global Oral Cholera Vaccine Revenue by Application (2021–2032)

5.2.1 Global Oral Cholera Vaccine Revenue by Application (2021–2026)

5.2.2 Global Oral Cholera Vaccine Revenue by Application (2027–2032)

5.2.3 Global Oral Cholera Vaccine Revenue Market Share by Application (2021–2032)

5.3 Global Oral Cholera Vaccine Price by Application (2021–2032)

6 Key Companies Profiled

6.1 PaxVax

6.1.1 PaxVax Company Information

6.1.2 PaxVax Description and Business Overview

6.1.3 PaxVax Oral Cholera Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 PaxVax Oral Cholera Vaccine Product Portfolio

6.1.5 PaxVax Recent Developments/Updates

6.2 Sanofi

6.2.1 Sanofi Company Information

6.2.2 Sanofi Description and Business Overview

6.2.3 Sanofi Oral Cholera Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Sanofi Oral Cholera Vaccine Product Portfolio

6.2.5 Sanofi Recent Developments/Updates

6.3 Valneva

6.3.1 Valneva Company Information

6.3.2 Valneva Description and Business Overview

6.3.3 Valneva Oral Cholera Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Valneva Oral Cholera Vaccine Product Portfolio

6.3.5 Valneva Recent Developments/Updates

6.4 EuBiologics

6.4.1 EuBiologics Company Information

6.4.2 EuBiologics Description and Business Overview

6.4.3 EuBiologics Oral Cholera Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 EuBiologics Oral Cholera Vaccine Product Portfolio

6.4.5 EuBiologics Recent Developments/Updates

6.5 United Biotech

6.5.1 United Biotech Company Information

6.5.2 United Biotech Description and Business Overview

6.5.3 United Biotech Oral Cholera Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 United Biotech Oral Cholera Vaccine Product Portfolio

6.5.5 United Biotech Recent Developments/Updates

6.6 Vabiotech

6.6.1 Vabiotech Company Information

6.6.2 Vabiotech Description and Business Overview

6.6.3 Vabiotech Oral Cholera Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Vabiotech Oral Cholera Vaccine Product Portfolio

6.6.5 Vabiotech Recent Developments/Updates

6.7 PaxVax

6.7.1 PaxVax Company Information

6.7.2 PaxVax Description and Business Overview

6.7.3 PaxVax Oral Cholera Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 PaxVax Oral Cholera Vaccine Product Portfolio

6.7.5 PaxVax Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oral Cholera Vaccine Industry Chain Analysis

7.2 Oral Cholera Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Cholera Vaccine Production Mode & Process Analysis

7.4 Oral Cholera Vaccine Sales and Marketing

7.4.1 Oral Cholera Vaccine Sales Channels

7.4.2 Oral Cholera Vaccine Distributors

7.5 Oral Cholera Vaccine Customer Analysis

8 Oral Cholera Vaccine Market Dynamics

8.1 Oral Cholera Vaccine Industry Trends

8.2 Oral Cholera Vaccine Market Drivers

8.3 Oral Cholera Vaccine Market Challenges

8.4 Oral Cholera Vaccine Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

PaxVax

Sanofi

Valneva

EuBiologics

United Biotech

Vabiotech

List of Tables

Table 1. Global Oral Cholera Vaccine Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Oral Cholera Vaccine Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Oral Cholera Vaccine Market Competitive Situation by Manufacturers in 2025

Table 4. Global Oral Cholera Vaccine Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Oral Cholera Vaccine Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Oral Cholera Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Oral Cholera Vaccine Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Oral Cholera Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Oral Cholera Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Oral Cholera Vaccine, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Oral Cholera Vaccine, Product Types and Applications

Table 12. Global Key Manufacturers of Oral Cholera Vaccine, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oral Cholera Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Cholera Vaccine Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Cholera Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Oral Cholera Vaccine Sales by Region (K Units), 2021–2026

Table 18. Global Oral Cholera Vaccine Sales Market Share by Region (2021–2026)

Table 19. Global Oral Cholera Vaccine Sales by Region (K Units), 2027–2032

Table 20. Global Oral Cholera Vaccine Sales Market Share by Region (2027–2032)

Table 21. Global Oral Cholera Vaccine Revenue by Region (US$ Million), 2021–2026

Table 22. Global Oral Cholera Vaccine Revenue Market Share by Region (2021–2026)

Table 23. Global Oral Cholera Vaccine Revenue by Region (US$ Million), 2027–2032

Table 24. Global Oral Cholera Vaccine Revenue Market Share by Region (2027–2032)

Table 25. North America Oral Cholera Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Oral Cholera Vaccine Sales by Country (K Units), 2021–2026

Table 27. North America Oral Cholera Vaccine Sales by Country (K Units), 2027–2032

Table 28. North America Oral Cholera Vaccine Revenue by Country (US$ Million), 2021–2026

Table 29. North America Oral Cholera Vaccine Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Oral Cholera Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Oral Cholera Vaccine Sales by Country (K Units), 2021–2026

Table 32. Europe Oral Cholera Vaccine Sales by Country (K Units), 2027–2032

Table 33. Europe Oral Cholera Vaccine Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Oral Cholera Vaccine Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Oral Cholera Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Oral Cholera Vaccine Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Oral Cholera Vaccine Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Oral Cholera Vaccine Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Oral Cholera Vaccine Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Oral Cholera Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Oral Cholera Vaccine Sales by Country (K Units), 2021–2026

Table 42. Latin America Oral Cholera Vaccine Sales by Country (K Units), 2027–2032

Table 43. Latin America Oral Cholera Vaccine Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Oral Cholera Vaccine Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Oral Cholera Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Oral Cholera Vaccine Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Oral Cholera Vaccine Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Oral Cholera Vaccine Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Oral Cholera Vaccine Revenue by Country (US$ Million), 2027–2032

Table 50. Global Oral Cholera Vaccine Sales (K Units) by Type (2021–2026)

Table 51. Global Oral Cholera Vaccine Sales (K Units) by Type (2027–2032)

Table 52. Global Oral Cholera Vaccine Sales Market Share by Type (2021–2026)

Table 53. Global Oral Cholera Vaccine Sales Market Share by Type (2027–2032)

Table 54. Global Oral Cholera Vaccine Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Oral Cholera Vaccine Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Oral Cholera Vaccine Revenue Market Share by Type (2021–2026)

Table 57. Global Oral Cholera Vaccine Revenue Market Share by Type (2027–2032)

Table 58. Global Oral Cholera Vaccine Price (US$/Unit) by Type (2021–2026)

Table 59. Global Oral Cholera Vaccine Price (US$/Unit) by Type (2027–2032)

Table 60. Global Oral Cholera Vaccine Sales (K Units) by Application (2021–2026)

Table 61. Global Oral Cholera Vaccine Sales (K Units) by Application (2027–2032)

Table 62. Global Oral Cholera Vaccine Sales Market Share by Application (2021–2026)

Table 63. Global Oral Cholera Vaccine Sales Market Share by Application (2027–2032)

Table 64. Global Oral Cholera Vaccine Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Oral Cholera Vaccine Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Oral Cholera Vaccine Revenue Market Share by Application (2021–2026)

Table 67. Global Oral Cholera Vaccine Revenue Market Share by Application (2027–2032)

Table 68. Global Oral Cholera Vaccine Price (US$/Unit) by Application (2021–2026)

Table 69. Global Oral Cholera Vaccine Price (US$/Unit) by Application (2027–2032)

Table 70. PaxVax Company Information

Table 71. PaxVax Description and Business Overview

Table 72. PaxVax Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. PaxVax Oral Cholera Vaccine Product

Table 74. PaxVax Recent Developments/Updates

Table 75. Sanofi Company Information

Table 76. Sanofi Description and Business Overview

Table 77. Sanofi Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Sanofi Oral Cholera Vaccine Product

Table 79. Sanofi Recent Developments/Updates

Table 80. Valneva Company Information

Table 81. Valneva Description and Business Overview

Table 82. Valneva Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Valneva Oral Cholera Vaccine Product

Table 84. Valneva Recent Developments/Updates

Table 85. EuBiologics Company Information

Table 86. EuBiologics Description and Business Overview

Table 87. EuBiologics Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. EuBiologics Oral Cholera Vaccine Product

Table 89. EuBiologics Recent Developments/Updates

Table 90. United Biotech Company Information

Table 91. United Biotech Description and Business Overview

Table 92. United Biotech Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. United Biotech Oral Cholera Vaccine Product

Table 94. United Biotech Recent Developments/Updates

Table 95. Vabiotech Company Information

Table 96. Vabiotech Description and Business Overview

Table 97. Vabiotech Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Vabiotech Oral Cholera Vaccine Product

Table 99. Vabiotech Recent Developments/Updates

Table 100. PaxVax Company Information

Table 101. PaxVax Description and Business Overview

Table 102. PaxVax Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. PaxVax Oral Cholera Vaccine Product

Table 104. PaxVax Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Oral Cholera Vaccine Distributors List

Table 108. Oral Cholera Vaccine Customers List

Table 109. Oral Cholera Vaccine Market Trends

Table 110. Oral Cholera Vaccine Market Drivers

Table 111. Oral Cholera Vaccine Market Challenges

Table 112. Oral Cholera Vaccine Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Oral Cholera Vaccine

Figure 2. Global Oral Cholera Vaccine Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Oral Cholera Vaccine Market Share by Type: 2025 & 2032

Figure 4. Euvichol-Plus Product Picture

Figure 5. DUKORAL Product Picture

Figure 6. Shanchol Product Picture

Figure 7. Others Product Picture

Figure 8. Global Oral Cholera Vaccine Market Value by Application (US$ Million), 2021–2032

Figure 9. Global Oral Cholera Vaccine Market Share by Application: 2025 & 2032

Figure 10. Preventive Campaigns

Figure 11. Outbreak Response

Figure 12. Global Oral Cholera Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Oral Cholera Vaccine Market Size (US$ Million), 2021–2032

Figure 14. Global Oral Cholera Vaccine Sales (K Units), 2021–2032

Figure 15. Global Oral Cholera Vaccine Average Price (US$/Unit), 2021–2032

Figure 16. Oral Cholera Vaccine Report Years Considered

Figure 17. Oral Cholera Vaccine Sales Share by Manufacturers in 2025

Figure 18. Global Oral Cholera Vaccine Revenue Share by Manufacturers in 2025

Figure 19. Top 5 and Top 10 Global Oral Cholera Vaccine Players: Market Share by Revenue in Oral Cholera Vaccine in 2025

Figure 20. Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Global Oral Cholera Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 22. North America Oral Cholera Vaccine Sales Market Share by Country (2021–2032)

Figure 23. North America Oral Cholera Vaccine Revenue Market Share by Country (2021–2032)

Figure 24. United States Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Canada Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Europe Oral Cholera Vaccine Sales Market Share by Country (2021–2032)

Figure 27. Europe Oral Cholera Vaccine Revenue Market Share by Country (2021–2032)

Figure 28. Germany Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. France Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. U.K. Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Italy Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Russia Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Asia Pacific Oral Cholera Vaccine Sales Market Share by Region (2021–2032)

Figure 34. Asia Pacific Oral Cholera Vaccine Revenue Market Share by Region (2021–2032)

Figure 35. China Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Japan Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. South Korea Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. India Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Australia Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. China Taiwan Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Southeast Asia Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Latin America Oral Cholera Vaccine Sales Market Share by Country (2021–2032)

Figure 43. Latin America Oral Cholera Vaccine Revenue Market Share by Country (2021–2032)

Figure 44. Mexico Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Brazil Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Argentina Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Middle East and Africa Oral Cholera Vaccine Sales Market Share by Country (2021–2032)

Figure 48. Middle East and Africa Oral Cholera Vaccine Revenue Market Share by Country (2021–2032)

Figure 49. Turkey Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Saudi Arabia Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. UAE Oral Cholera Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Global Sales Market Share of Oral Cholera Vaccine by Type (2021–2032)

Figure 53. Global Revenue Market Share of Oral Cholera Vaccine by Type (2021–2032)

Figure 54. Global Oral Cholera Vaccine Price (US$/Unit) by Type (2021–2032)

Figure 55. Global Sales Market Share of Oral Cholera Vaccine by Application (2021–2032)

Figure 56. Global Revenue Market Share of Oral Cholera Vaccine by Application (2021–2032)

Figure 57. Global Oral Cholera Vaccine Price (US$/Unit) by Application (2021–2032)

Figure 58. Oral Cholera Vaccine Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oral Rabies Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Therapeutic Proteins and Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Live Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cholera Vaccines Oral Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hog Cholera Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cholera Treatment Market Research Report 2024

Oral Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccine Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccine for Influenza Market Research Report 2025

Oral Vaccines for Aquatic Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Bordetella Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Delivery Vaccines Market Research Report 2025

Global Pandemic Influenza Vaccine Market Research Report 2025

Global Human Oral Vaccine Market Research Report 2024

Oral Typhoid Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti diarrheal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions